A retrospective analysis of incident pregnancy in phase 1 and 2a HIV-1 vaccine study participants does not support concern for adverse pregnancy or birth outcomes

Table 2 Demographics of Women of Reproductive Potential

Total participants of reproductive potential		2673
Country		N	%
Botswana		8	0.30%
Brazil		62	2.30%
Dominican Republic		8	0.30%
Haiti		27	1.00%
Jamaica		18	0.70%
Malawi		1	0.00%
Peru		81	3.00%
Puerto Rico		13	0.50%
South Africa		471	18%
Switzerland		158	5.90%
Tanzania		15	0.60%
Thailand		56	2.10%
Trinidad and Tobago		19	0.70%
US		1726	65%
Zambia		10	0.40%
Ethnicity		N	%
Hispanic or Latino		282	11%
Not Hispanic or Latino		2251	84%
Unknown		140	5.20%
Race		N	%
White		1446	54%
Black/African American		854	32%
Asian/Pacific Islander		105	3.90%
Native American/Alaskan Native		12	0.40%
Hawaiian/Pacific Islander		4	0.10%
Multiracial		100	3.70%
Other or Unknown		152	5.70%
Age at enrollment		N	%
18–20		407	15%
21–30		1455	54%
31–40		496	19%
41–50		309	12%
50+		6	0.20%
Median	26
Mean	28.3
BMI		N	%
Underweight (< 18.5)		50	1.90%
Normal weight (18.5–24.9)		1096	41%
Overweight (25–29.9)		543	20%
Obese (> 30)		516	19%
Unknown		468	18%
Median	24.7
Mean	26.2

ISSN: 1471-2334